GRTS US39868T1051

Report

Real-time Estimate Cboe BZX - 03:31 2022-08-17 pm EDT
4.455	USD		-6.21%

07:01a	Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
08/15	Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors	AQ
08/15	Gritstone bio, Inc. Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of GRANITE, Individualized Neoantigen Vaccine for Solid Tumors	CI

Calendar

Event chart GRITSTONE BIO, INC.

Upcoming events on GRITSTONE BIO, INC.

11/15/22		Q3 2022 Earnings Release (Projected)
03/09/23		FY 2022 Earnings Release (Projected)
05/04/23		Q1 2023 Earnings Release (Projected)
08/03/23		Interim 2023 Earnings Release (Projected)

Past events on GRITSTONE BIO, INC.

08/04/22 \| 04:30pm		Interim 2022 Earnings Call
08/04/22		Interim 2022 Earnings Release
06/17/22 \| 12:00pm		Annual General Meeting
06/04/22 \| 09:00am		American Society of Clinical Oncology Meeting - Abstract Number TPS3635
05/24/22 \| 07:00am		H.C. Wainwright Global Life Sciences Investment Conference
05/12/22 \| 04:00pm		Q1 2022 Earnings Call
05/05/22 \| 04:05pm		Q1 2022 Earnings Release
05/03/22		Shareholders Meeting - Q&A
04/13/22 \| 09:00am		American Association of Cancer Research Meeting - Abstract Number 4149
04/12/22 \| 02:30pm		American Association of Cancer Research Meeting - Abstract Number 3578

Past dividends on GRITSTONE BIO, INC.

- No events available -

Annual results

Fiscal Period : December		2017	2018	2019	2020	2021	2022
Sales M $	Released Forecast Spread		1,19 2,00 -41%	4,37 4,56 -4,3%	4,04 3,89 3,7%	48,2 48,0 0,39%	19,2
Operating income (EBITDA) M $	Released Forecast Spread	-39,8	-61,6 -53,2 -16%	-93,2 -93,5 0,33%	-99,4 -103 3,1%	-68,9 -65,8 -4,7%	-120
Operating profit (EBIT) M $	Released Forecast Spread		-65,6 -58,1 -13%	-97,9 -95,4 -2,6%	-106 -107 0,58%	-75,2 -73,7 -2,1%	-124
Pre-Tax Profit (EBT) M $	Released Forecast Spread		-64,8 -64,9 0,19%	-94,4 -93,0 -1,5%	-105 -105 -0,25%	-75,1 -73,9 -1,6%	-123
Net income M $	Released Forecast Spread	-41,4	-64,8 -64,9 0,19%	-94,4 -93,0 -1,5%	-105 -105 -0,25%	-75,1 -73,9 -1,6%	-123
EPS $	Released Forecast Spread	-20,7	-7,26 -1,90 -283%	-2,81 -2,63 -6,7%	-2,79 -2,71 -2,8%	-0,95 -1,08 12%	-1,55
Announcement Date		05/04/2018	03/28/2019	03/11/2020	03/11/2021	03/10/2022	-

Quarterly results

Fiscal Period : December

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q2

2022 Q3

Sales
M $

Released
Forecast
Spread

2,84
2,24
27%

2,61
2,24
17%

3,06
2,86
7,0%

7,19
4,21
71%

5,47
3,19
71%

3,26

Operating profit
(EBIT)
M $

Released
Forecast
Spread

-25,2
-32,5
23%

-28,2
-28,8
2,4%

-29,8
-28,3
-5,4%

-29,0
-30,5
5,2%

-29,7
-31,3
5,2%

-32,7

Pre-Tax Profit
(EBT)
M $

Released
Forecast
Spread

-25,1
-32,9
24%

-28,1
-28,8
2,4%

-29,8
-28,6
-4,0%

-28,9
-30,5
5,2%

-29,5
-31,6
6,6%

-32,2

Net income
M $

Released
Forecast
Spread

-25,1
-31,6
20%

-28,1
-27,5
-2,3%

-29,8
-28,6
-4,0%

-28,9
-30,5
5,2%

-29,5
-31,6
6,6%

-32,2

EPS
$

Released
Forecast
Spread

-0,33
-0,56
41%

-0,36
-0,47
24%

-0,36
-0,40
9,2%

-0,34
-0,36
5,6%

-0,34
-0,41
17%

-0,42

Announcement Date

08/05/2021

11/03/2021

03/10/2022

05/05/2022

08/04/2022

Previous year

Next Year

Upcoming sector events for GRITSTONE BIO, INC.

08/17/22		WUXI BIOLOGICS (CAYMAN) INC. : Interim 2022 Earnings Release
08/17/22		CSL LIMITED : FY 2022 Earnings Release
10/25/22		SAMSUNG BIOLOGICS CO.,LTD. : Q3 2022 Earnings Release (Projected)
10/25/22		BIOGEN INC. : Q3 2022 Earnings Release (Projected)
02/02/23		BIOGEN INC. : FY 2022 Earnings Release (Projected)
02/15/23		CSL LIMITED : Interim 2023 Earnings Release (Projected)
03/09/23		SAMSUNG BIOLOGICS CO.,LTD. : FY 2022 Earnings Release (Projected)
03/20/23		WUXI BIOLOGICS (CAYMAN) INC. : FY 2022 Earnings Release (Projected)
04/25/23		BIOGEN INC. : Q1 2023 Earnings Release (Projected)
04/26/23		SAMSUNG BIOLOGICS CO.,LTD. : Q1 2023 Earnings Release (Projected)

More events

Past sector events for GRITSTONE BIO, INC.

07/27/22 \| 02:43am		SAMSUNG BIOLOGICS CO.,LTD. : Interim 2022 Earnings Release
07/20/22 \| 07:00am		BIOGEN INC. : Interim 2022 Earnings Release
05/16/22 \| 02:42am		SAMSUNG BIOLOGICS CO.,LTD. : Q1 2022 Earnings Release
05/03/22 \| 07:00am		BIOGEN INC. : Q1 2022 Earnings Release
03/22/22		WUXI BIOLOGICS (CAYMAN) INC. : FY 2021 Earnings Release
02/16/22		CSL LIMITED : Interim 2022 Earnings Release
02/03/22		BIOGEN INC. : FY 2021 Earnings Release
01/24/22 \| 03:25am		SAMSUNG BIOLOGICS CO.,LTD. : FY 2021 Earnings Release
10/26/21 \| 03:23am		SAMSUNG BIOLOGICS CO.,LTD. : Q3 2021 Earnings Release
10/20/21 \| 07:00am		BIOGEN INC. : Q3 2021 Earnings Release

More events

Analysis

AstraZeneca : invests in Imperial's self-amplifying RNA technology with eye on future drugs